(2008) Clinical Evidence for Utilization of the A3 Adenosine Receptor as a Target to Treat Rheumatoid Arthritis: Data from a Phase II Clinical Trial. J. Rheumatology. 35:1-7. Ochaion A, Bar-Yehuda S, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback